TY - JOUR
T1 - Albuterol–budesonide fixed-dose combination rescue inhaler for asthma
T2 - a plain language summary of the MANDALA study
AU - Papi, Alberto
AU - Chipps, Bradley E.
AU - Beasley, Richard
AU - Panettieri, Reynold A.
AU - Israel, Elliot
AU - Cooper, Mark
AU - Dunsire, Lynn
AU - Jeynes-Ellis, Allison
AU - Rees, Robert
AU - Albers, Frank C.
AU - Cappelletti, Christy
N1 - Publisher Copyright:
© The Author(s), 2024.
PY - 2024/1/1
Y1 - 2024/1/1
N2 - What is this summary about? This summary describes the results of a clinical study called MANDALA that was published in the New England Journal of Medicine in 2022. In the MANDALA study, researchers looked at a new asthma rescue inhaler that contains both albuterol and budesonide in a single inhaler (known as albuterol–budesonide, AIRSUPRA™). This summary describes the results for people aged 18 yearsand older who took part in the study.
AB - What is this summary about? This summary describes the results of a clinical study called MANDALA that was published in the New England Journal of Medicine in 2022. In the MANDALA study, researchers looked at a new asthma rescue inhaler that contains both albuterol and budesonide in a single inhaler (known as albuterol–budesonide, AIRSUPRA™). This summary describes the results for people aged 18 yearsand older who took part in the study.
UR - http://www.scopus.com/inward/record.url?scp=85192039162&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85192039162&partnerID=8YFLogxK
U2 - 10.1177/17534666241232264
DO - 10.1177/17534666241232264
M3 - Article
C2 - 38698565
AN - SCOPUS:85192039162
SN - 1753-4658
VL - 18
JO - Therapeutic Advances in Respiratory Disease
JF - Therapeutic Advances in Respiratory Disease
ER -